NDC 50102-120-01 - AUBRA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-120
- Requested NDC
- 50102-120-01
- Package NDCs from labels
- 50102-120-00, 50102-120-01, 50102-120-48, 50102-120-10, 50102-120-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AUBRA - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-120-03 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-03 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-120-00 | EA - Each | 50102-120 | d9bee6d9-aa9d-4898-93de-438dae2bb869 | 1 | 2022-06-06 |
| 50102-120-01 | EA - Each | 50102-120 | 8b796782-496f-4ed0-b025-66127b0fc3f9 | 1 | 2013-11-04 |
| 50102-120-03 | EA - Each | 50102-120 | c2265cdf-ed8f-437d-9e4b-312af0119f71 | 1 | 2017-09-11 |
| 50102-120-10 | EA - Each | 50102-120 | 5c1fb698-e254-4b92-8ed9-eb87d3604632 | 1 | 2017-09-11 |
| 50102-120-48 | EA - Each | 50102-120 | 8a66d499-33ea-4443-a859-d114a3240255 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Etonogestrel and Ethinyl Estradiol Vaginal | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | AvKARE | 05e172aa-e18a-427b-e063-6294a90ae22f | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Calamine | CALAMINE, PRAMOXINE HCL | United Natural Foods, Inc. dba UNFI | 0bc1a9b4-1210-4d9a-bbd2-40e9225e86ea | 2026-09-04 | Warnings, Adverse reactions | 1K09F3G675 |
| LEVONORGESTREL | LEVONORGESTREL | YYBA CORP | 5a71b870-9a0a-7997-e063-6294a90a882c | 2026-09-01 | Warnings | 5W7SIA7YZW |
| Calamine | FERRIC OXIDE RED | Your Military Exchanges | af95a66c-f063-4019-80c6-6f7dc4fee4d8 | 2026-08-28 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine Plus | CALAMINE, PRAMOXINE HYDROCHLORIDE | Kroger Company | 44fdd5a4-3cac-15e5-e063-6294a90adb52 | 2026-08-26 | Warnings | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | The Kroger Co. | 9ddcd6ba-1aed-48f8-a91a-54bd6f0d9308 | 2026-08-06 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE AND ZINC OXIDE | Marie's Original Formulas LLC | 57110309-9a3d-025f-e063-6394a90a015a | 2026-07-22 | Warnings | 1K09F3G675 |
| Calamine | CALAMINE AND ZINC OXIDE | Marie's Original Formulas LLC | 571083ce-cd35-a638-e063-6394a90ae4c7 | 2026-07-20 | Warnings | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Better Living Brands, LLC | c7ef0ef3-6861-4b94-af4b-371fee8c1f3d | 2026-07-16 | Warnings, Adverse reactions | 1K09F3G675 |
| SheWise | LEVONORGESTREL | GLENMARK THERAPEUTICS INC., USA | 7be13a7e-b4ff-4fe1-82a6-f9914596d72a | 2026-07-15 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | GLENMARK THERAPEUTICS INC., USA | 07567b80-d8a1-41c0-95e4-33afa584bbc4 | 2026-07-15 | Warnings | 5W7SIA7YZW |
| Twirla | LEVONORGESTREL/ETHINYL ESTRADIOL | Agile Therapeutics, Inc. | bcaf8db0-1750-425d-b008-255b5e7a9cc6 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U 5W7SIA7YZW |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Target Corporation | 36602b7a-99c0-f6a4-e063-6294a90a8758 | 2026-06-29 | Warnings | 1K09F3G675 |
| OPTION 2 | LEVONORGESTREL | L. Perrigo Company | 7d7b9e61-9f3d-477d-b74d-b0cc725f9bba | 2026-06-25 | Warnings | 5W7SIA7YZW |
| CalaSoothe | CALAMINE, MENTHOL, AND ZINC OXIDE | Dynarex Corporation | 54f12005-acfe-4821-e063-6394a90ac304 | 2026-06-24 | Warnings | 1K09F3G675 |
| Calamine, Pramoxind HCl | CALAMINE, PRAMOXIND HCL | H E B | 4a7a0b09-d9bc-e752-e063-6394a90a9f2c | 2026-06-15 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine, Zinc Oxide | CALAMINE, ZINC OXIDE | H E B | 4a79259e-64ac-d187-e063-6294a90a78db | 2026-06-15 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE AND ZINC OXIDE | Pharma Nobis, LLC | fbcfa541-beda-06de-e053-6294a90a9298 | 2026-05-26 | Warnings | 1K09F3G675 |
| Levonorgestrel | LEVONORGESTREL | Rugby Laboratories | 076126e4-9d76-45cd-a86b-5b35c56b620a | 2026-05-13 | Warnings | 5W7SIA7YZW |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | CVS Pharmacy | db6f518d-3a0e-43f8-8d19-7382d9b7ff1c | 2026-05-11 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.